INTRODUCTION
Cervical cancer is the second most common cancer in women worldwide (1) . The incidence and death rates for cervical cancer are higher in Uygur women than in other ethnic groups in China, and many genes have shown aberrant expression levels in Uygur women with cervical cancer (2) . High-risk human papillomavirus (hr-HPV) is a necessary factor in cervical cancer and has an etiologic association with it, especially HPV16 and HPV18, which are the 2 main hr-HPV types (3) (4) (5) . Cervical cancer develops via multiple steps from premalignant cervical lesions to malignant invasive cancer and is divided into 5 stages: normal, cervical intraepithelial neoplasia 1 (CIN1), CIN2, CIN3 and invasive cervical carcinoma (6) . During these processes, there is an increasing trend toward progression: approximately, 10% of CIN1 lesions and 20% of CIN2 lesions were shown to progress Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang hypermethylated genes have been discovered in cervical cancer (13) (14) (15) . However, few of these hypermethylated genes are sensitive enough for the detection of CIN2 or higher, and without simultaneously false-positive results in samples from women with CIN1 or lower. Hypermethylation in the promoters of tumor suppresser genes has been reported to be an early event in cervical carcinogenesis (16) and therefore may be a useful marker for the early detection of cervical cancer. In the current study, we selected 2 tumor suppressor genes, HS3ST2 (for heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2) and CCNA1 (for cyclin A1), from a range of candidate genes and assessed their suitability as markers for the early detection of cervical cancer in Uygur women in Xinjiang, China.
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (HS3ST2 gene) participates in the final modification step of glycosaminoglycan chains of heparan sulfate proteoglycans (HSPGs), which are important to cell migration, growth and adhesion by interaction with a wide range of growth factors such as morphogens, cytokines and extracellular matrix (17, 18) . The high frequency of methylation in the promoter of HS3ST2 gene has been found in colorectal cancer, cervical cancer, breast cancer, lung cancer and pancreatic cancer (7, (19) (20) (21) (22) . Cyclin A1 (CCNA1 gene) is a cell-cycle regulatory factor; it contributes to G1 to S cell cycle progression in somatic cells and plays a role in the maintenance of cell proliferation. CCNA1 overexpression enhances S phase entry, which is consistent with an oncogenic function (23) . CCNA1 may also be involved in cell apoptosis and DNA-doublestrand-break repair by interacting with Ku70 (24, 25) . The disorder of CCNA1 gene expression is closely related to tumor development (23, 26) . A high degree of CCNA1 promoter methylation (93.3%) has been found in invasive HPV-associated cervical cancer, but no methylation in CCNA1 promoter has been found in normal cells, nor in low-grade squamous intraepithelial lesions (LSILs) (27) . CCNA1 (p=0.015) showed higher methylation frequency in HPV16-positive head and neck squamous cell carcinoma (HNSCC) compared with HPV16-negative tumors; therefore, CCNA1 methylation may play a crucial role in HPV16-induced carcinogenesis of HNSCC independent of p53 (28) .
Although there is a high degree of CCNA1 and HS3ST2 gene promoter methylation in cervical cancer and a similar increasing progression trend with the severity of the cervical lesions, whether HS3ST2 and CCNA1 genes are good enough to be the molecular marker in cervical cancer is still not clear. Therefore, we investigated the relationship among promoter methylation, infection with HPV16 and HPV18, and expression of HS3ST2 and CCNA1 genes to see whether these 2 genes are specific to the cervical cancer and have the potential to be used for clinical screening of cervical cancer.
MATERIALS AND METHODS

Samples of human cervical tissues
All of the cervical tissues were obtained from hospitalized Uygur women in Xinjiang, China, from 2009 to 2013. Cervical tissues were obtained either surgically or by biopsy. Tissues were transported to the laboratory immediately after collection and stored in liquid nitrogen for the genomic DNA and RNA extraction. Tissues were examined by at least 2 gynecologic pathologists to ensure the quality of tissue samples and the presence of tumors in the cervical cancer tissues. The histologic type and grade of the tumors was classified according to the World Health Organization criteria (29) . Approvals were obtained from the ethics committees of the hospitals and from each patient. Patients did not receive chemotherapy or radiotherapy before or at the time when tissues were collected. The 110 cervical tissues from Uygur women were classified as 40 normal cervical tissues, 10 CIN1, 10 CIN2, 10 CIN3 and 40 cervical cancer tissues.
DNA preparation and detection of HPV
Genomic DNA was extracted with the SK1252 Genomic DNA Isolation mini kit (Shanghai Sangon Biological Engineering Technology and Services Company) according to the manufacturer's protocol. HPV detection and typing were performed in all samples; the presence of HPV16 and HPV18 was detected by polymerase chain reaction (PCR) using HPV16-and HPV18-specific primers (Tab. I).
DNA modification by bisulfite treatment and methylationspecific PCR
One microgram of genomic DNA from each tissue sample was subjected to the bisulfite treatment at 55°C for 16 hours, according to the instructions for the CpGenome DNA modification kit S7820 (Chemicon, Temecula, CA, USA). The modified DNA was then purified, followed by ethanol precipitation and then stored at -80°C. The M and U set of primers were obtained from the published literature; the conditions for the methylation-specific PCR (MSP) were given in Table I .
RNA preparation and analysis
Expression of HS3ST2 and CCNA1 genes in the 10 methylated and 10 unmethylated cervical tissues was examined by reverse transcription PCR (RT-PCR). Total RNA was extracted using the Trizol reagent according to the manufacturer's protocol. Each RNA sample was subjected to cDNA synthesis using an oligo(dt) primer and reverse transcriptase (Fermentas, Hanover, MD, USA). The cDNA was then amplified by PCR; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal control. Five microliters of PCR products was stained with ethidium bromide on preparation, and those products were visualized using a UV transilluminator. The nucleotide sequence of each primer and the amplification conditions were given in Table I .
Quality control
For MSP, modified DNA from peripheral blood mononuclear cells was used as unmethylated control for the HS3ST2 and CCNA1 genes. Modified DNA from H23 cell lines for HS3ST2 gene and HeLa cell lines for CCNA1 gene were used as methylated control. Unmodified DNA was used as negative control. MiliQ water without DNA template was used to check the contamination. MSP was performed twice on each sample to diminish the falsepositive bands.
Statistical analysis
Difference in methylation levels between 2 or more groups was compared using the Mann-Whitney U test and Kruskal-Wallis test, respectively. Associations between numerical parameters were analyzed using chi-square test with continuity correction when appropriate. Differences in gene expression levels between 2 groups were analyzed by t test. All statistical analyses were carried out using SPSS version 17.0 software package. A p value <0.05 was considered as statistically significant.
RESULTS
Frequency of methylation and infection with HPV16/18 in the multistep cervical carcinogenesis
With respect to HS3ST2, none of the 40 normal cervix samples and the 10 CIN1 tissue samples were methylated; however, 5 of the 10 CIN2 samples, 7 of the 10 CIN3 samples and 37 of the 40 cervical cancer tissues were methylated, giving a methylation rate of 50%, 70% and 92.5%, respectively. An increasing pattern of methylation frequency was also found for CCNA1, with the methylation rates being 2.5%, 0%, 30%, 70% and 87.5% for normal cervix, CIN1, CIN2, CIN3 and cervical cancer tissues, respectively. The methylation frequencies of both HS3ST2 and CCNA1 were correlated to the severity of the cervical lesion (both p<0.001) (Tab. II; Fig. 1 ).
Sequencing of the promoters of HS3ST2 and CCNA1 genes showed that methylated targets in cancer cell lines and some selected cervical cancer samples contained CpGs, whereas unmethylated targets in peripheral blood mononuclear cells and some selected normal tissues contained TpGs (Fig. 2) .
HS3ST2 and CCNA1 gene expression in methylated and unmethylated cervical tissues including cervical cancer, CIN and normal cervix
The mRNA levels of HS3ST2 and CCNA1 genes were significantly higher in the 10 cervical tissues without methylation than in the 10 cervical tissues with methylation. In the 10 methylation-positive tissues, the absorbance ratios of the 2 genes were 0.072±0.011 and 0.043±0.007; however, in the 10 methylation-negative tissues, they were 0.863±0.182 and 0.744±0.256 (both p<0.001) (n=3) (Fig. 3) . e358
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Correlation between the infection with HPV16/18 and methylation of HS3ST2 and CCNA1 genes
Infection with HPV16/18 was correlated to methylation of HS3ST2 and CCNA1 in the 60 samples including high-grade squamous intraepithelial lesions (HSILs) and cancer. HS3ST2 and CCNA1 genes showed higher methylation frequencies in HPV16/18-positive patients compared with in HPV16/18-negative patients (both p<0.05; Tab. III).
Diagnostic performance of detection for HPV16/18 and the promoter methylation of HS3ST2 and CCNA1
The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of gene methylation and HPV16/18 infection for lesions of different grades are shown in Table IV . Methylation in the promoters of HS3ST2 and CCNA1 genes had (i) high specificities and PPVs (100%, 100% and 98%, 97.8%, respectively) and high sensitivities (81.7%, 75%) for HSIL and cancer, and (ii) high NPVs (82%, 76.6%) for normal and LSIL (CIN1) tissues. Moreover, the combined methylation analysis of the 2 genes had a sensitivity of 88.3% for HSIL and cancer, and a specificity of 98% for normal and LSIL tissues. HPV16/18 infection, however, showed a lower specificity (88%) for normal and LSIL than the methylation detection; the PPV and NPV of HPV16/18 infection were also lower than the methylation detection (Tab. IV).
DISCUSSION
With a long preinvasive phase that spans years, cervical cancer is an ideal disease model for early-stage investigation. Moreover, the strong association between cervical cancer and hr-HPV, as in other cancers that are virally induced, provides a good target to explore the correlation between the potential markers and the infection.
Our results showed that the level of methylation in the promoters of HS3ST2 and CCNA1 genes increased with the severity of cervical lesions. Further, methylation in the promoters of HS3ST2 and CCNA1 genes decreased the expression of the 2 genes. Normal cervix was almost absent of HS3ST2 and CCNA1 methylation, whereas, there was a high level of HS3ST2 and CCNA1 methylation in HSIL/cancer (81.7% and 75%, respectively). Finally, to make a comprehensive analysis for the early detection of cervical cancer, the combined methylation of the 2 genes was analyzed, which showed a higher sensitivity of 88.3% for HSIL/cancer and a specificity of 98% for normal/LSIL. Methylation detection may have a potential to improve the current screening method of hr-HPV detection, which has a relatively high false positivity in cervical cancer scraping. As for the sensitivity for HSIL, the detection of the methylation of HS3ST2 promoter was similar to the detection of HPV16/18 (p=0.219). Therefore, there is a need to improve the sensitivity of methylation detection for HSIL. However, it is known that only a portion of HSIL cases progress to cervical cancer, if they are not well treated (12) . In other words, if we can verify that hypermethylated HS3ST2 and CCNA1 genes are the crucial biomarkers that have the ability to predict the part of HSIL that will develop into cervical cancer, then we will not need to find all HSIL patients or at least improve the accuracy of treatment. To prove the feasibility of these 2 markers for the early detection of cervical cancer, we may hypothesize that only HS3ST2 and CCNA1 methylation-positive lesions are propelled to progress and therefore need treatment. A good way to verify that is to invite the patients diagnosed with In conclusion, the data above might suggest the capa city of the 2 hypermethylated genes to be applied for early detection. We showed that both HS3ST2 and CCNA1 genes had a high methylation frequency in their promoters that increased with the severity of cervical cancer lesions. Just like the HPV-CIN lesions have a greater possibility of progressing to invasive cervical cancer, on the possible correlation with infection with HPV16/18, we probably have indirect evidence for the hypothesis that hypermethylated HS3ST2 and CCNA1 may be the critical molecular markers that lead to HPV-induced cervical cancer, which may be of great value for population-based cervical cancer scraping to observe whether it could be an indication for a direct referral by the gynecologists. Although the hypermethylated HS3ST2 and CCNA1 genes may have the possibility for, and a clinical value in, being used for cervical cancer screening, better or additional hypermethylated markers should be combined to improve the sensitivity, without losing the specificity for normal/LSIL. HSIL to participate in a long-term follow-up program to analyze the possible link between methylation status and regression/progression of the lesions. However, it is very hard to carry out this program and the results can easily be flawed by different types of methodologic biases (29) .
Given that it is hard to observe the relationship directly, we select another way to verify it indirectly. If we can verify that the 2 hypermethylated genes are the critical molecular markers and play a role in tumor progression in a direct or indirect way whenever possible, we will have further evidence to prove the feasibility of methylation-positive scraping in cervical cancer. Both HPV16/18 infection and methylation frequency of HS3ST2 and CCNA1 genes are at very high levels in cervical cancer; furthermore, both have an increasing trend that goes with the severity of the cervical lesion, which may imply a correlation between them. It is well known that infection with hr-HPV is a necessary factor in cervical cancer and has an etiologic association with it (3) (4) (5) . Therefore, we investigated the relationship between the infection with HPV16/18 and methylation of HS3ST2 and CCNA1 in the 60 HSIL and cancer cases, and found a high frequency of HPV16/18 infection and promoter methylation. The HS3ST2 and CCNA1 methylation frequency was higher in HPV16/18-positive lesions than in HPV16/18negative lesions (p=0.008, p=0.01, respectively). These results may suggest a crucial role for the 2 analyzed genes in cervical carcinogenesis, and their methylation status may have prognostic significance for HPV-associated cervical cancer. How infection with HPV16/18 has an effect on the promoter methylation of HS3ST2 and CCNA1 genes was unclear, a previous study reported that the physical state of HPV had the potential to affect the methylation of CCNA1 in cervical cancer (30) . However, overexpression of CCNA1 was observed in some neoplasms such as prostate cancer and acute myelocytic leukemia (AML) (31, 32) , where the expression of CCNA1 is related to the degree of malignant disease. CCNA1 may function as both an oncogene and a tumor suppressor gene. As a tumor suppressor gene, CCNA1 might be involved in cell apoptosis and DNA-double-strand-break repair by interacting with Ku70 (24, 25) .
We showed a correlation between infection with HPV16/18 and the methylation of HS3ST2 and CCNA1 genes, which may be useful for the early detection of cervical cancer. However, the number of samples we used in the present study was still small (n=110), especially the number of CIN tissues (n=30). Therefore, more samples, in particular CIN samples, should be used in future studies. The molecular mechanism of the correlation between infection with HPV16/18 and methylation of HS3ST2 and CCNA1 genes is still unclear to us and should be investigated as well in future studies to confirm whether and how the HPV16/18 affect the promoters' methylation of the 2 genes in vitro. It is noteworthy that a number of methylation-positive samples were from
